https://www.clinicalobserver.com/ hourly 1 https://www.clinicalobserver.com/research hourly 0.8 https://www.clinicalobserver.com/policy hourly 0.8 https://www.clinicalobserver.com/biotech hourly 0.8 https://www.clinicalobserver.com/hospitals hourly 0.8 https://www.clinicalobserver.com/public-health hourly 0.8 https://www.clinicalobserver.com/opinion hourly 0.8 https://www.clinicalobserver.com/policy/fda-approves-rybrevant-faspro-for-head-and-neck-cancer 2026-11-05T22:56:31.619Z 0.6 https://www.clinicalobserver.com/public-health/wisconsin-infant-dies-in-measles-outbreak-state-reports 2026-11-05T22:32:26.891Z 0.6 https://www.clinicalobserver.com/biotech/novartis-reports-tumors-in-children-given-zolgensma 2026-11-05T20:29:31.883Z 0.6 https://www.clinicalobserver.com/public-health/wisconsin-infant-dies-in-measles-outbreak-first-state-death-since-1990 2026-11-05T19:12:19.631Z 0.6 https://www.clinicalobserver.com/hospitals/sharon-regional-closes-emergency-department-will-suspend-all-services-by-friday 2026-11-05T17:59:05.393Z 0.6 https://www.clinicalobserver.com/biotech/rasonque-sales-hit-198-million-in-first-five-weeks 2026-11-05T13:08:03.440Z 0.6 https://www.clinicalobserver.com/policy/utah-allows-ai-to-prescribe-acne-drugs-without-doctor-visit 2026-11-04T22:23:45.954Z 0.6 https://www.clinicalobserver.com/public-health/pennsylvania-reports-sixth-measles-associated-death-as-cases-reach-1-467 2026-11-04T22:38:33.593Z 0.6 https://www.clinicalobserver.com/public-health/iowa-hhs-reports-50-measles-cases-and-warns-of-continued-spread 2026-11-04T19:27:49.713Z 0.6 https://www.clinicalobserver.com/hospitals/cvs-health-to-split-into-pharmacy-and-insurance-companies 2026-11-05T00:23:17.426Z 0.6 https://www.clinicalobserver.com/research/novartis-posts-phase-3-data-for-177lu-psma-617-in-hormone-sensitive-prostate 2026-11-04T16:29:45.730Z 0.6 https://www.clinicalobserver.com/biotech/former-madrigal-executive-sues-over-rezdiffra-safety-concerns 2026-11-05T12:38:07.833Z 0.6 https://www.clinicalobserver.com/policy/fda-panel-questions-evidence-for-syd-101-myopia-drops 2026-11-04T01:59:18.738Z 0.6 https://www.clinicalobserver.com/policy/fda-grants-tentative-approval-to-dr-reddy-s-generic-hiv-prevention-shot 2026-11-03T20:59:43.549Z 0.6 https://www.clinicalobserver.com/public-health/child-dies-from-measles-in-new-york-state-first-in-30-years 2026-11-03T16:06:58.838Z 0.6 https://www.clinicalobserver.com/public-health/ebola-outbreak-kills-more-than-5-300-people-africa-cdc-says 2026-11-03T13:23:09.985Z 0.6 https://www.clinicalobserver.com/public-health/new-york-reports-first-measles-associated-death-in-more-than-30-years 2026-11-03T05:54:25.869Z 0.6 https://www.clinicalobserver.com/research/base-editing-corrects-alpha-1-antitrypsin-mutation-in-seven-patients 2026-11-02T22:07:08.424Z 0.6 https://www.clinicalobserver.com/public-health/washington-state-resident-dies-from-h5n1-bird-flu-after-cattle-exposure 2026-11-02T20:58:51.893Z 0.6 https://www.clinicalobserver.com/public-health/yakima-county-reports-bird-flu-death-after-dairy-exposure 2026-11-02T20:40:36.778Z 0.6 https://www.clinicalobserver.com/policy/fda-grants-priority-review-to-uniqure-huntingtons-gene-therapy 2026-11-02T19:14:18.561Z 0.6 https://www.clinicalobserver.com/research/fertility-firm-pauses-marketing-of-three-parent-ivf-after-stat-probe 2026-11-02T13:27:23.185Z 0.6 https://www.clinicalobserver.com/public-health/fda-warns-against-once-upon-a-farm-toddler-bars-after-choking-reports 2026-11-02T07:30:50.852Z 0.6 https://www.clinicalobserver.com/policy/fda-approves-mercks-oral-pcsk9-inhibitor-lipfendra 2026-11-01T18:41:55.039Z 0.6 https://www.clinicalobserver.com/public-health/us-measles-cases-more-than-double-2025-total-before-paho-review 2026-11-01T17:11:54.505Z 0.6 https://www.clinicalobserver.com/policy/eu-approves-keytruda-plus-padcev-for-muscle-invasive-bladder-cancer 2026-11-01T15:59:31.227Z 0.6 https://www.clinicalobserver.com/policy/fda-grants-accelerated-approval-to-voceryq-for-recurrent-respiratory 2026-11-01T17:23:10.806Z 0.6 https://www.clinicalobserver.com/policy/fda-removes-black-box-warnings-from-three-more-menopause-patches 2026-10-30T16:52:58.673Z 0.6 https://www.clinicalobserver.com/biotech/lilly-s-retatrutide-tops-ozempic-in-phase-3-diabetes-trial 2026-10-30T20:53:29.931Z 0.6 https://www.clinicalobserver.com/biotech/geron-ends-phase-3-imetelstat-myelofibrosis-trial 2026-10-30T14:29:56.481Z 0.6 https://www.clinicalobserver.com/public-health/e-coli-clusters-tied-to-illinois-and-california-pumpkin-farms 2026-10-31T23:56:14.720Z 0.6 https://www.clinicalobserver.com/policy/hhs-lets-compounding-pharmacies-make-six-unapproved-peptides 2026-11-02T13:40:24.264Z 0.6 https://www.clinicalobserver.com/biotech/lilly-retatrutide-doubles-ozempic-weight-loss-in-diabetes-trial 2026-10-30T16:15:31.018Z 0.6 https://www.clinicalobserver.com/research/bayer-s-finerenone-lowers-albumin-in-type-1-diabetes-kidney-disease-trial 2026-10-30T17:15:10.066Z 0.6 https://www.clinicalobserver.com/public-health/congos-ebola-cases-surpass-10-000-as-outbreak-spreads 2026-11-02T18:08:49.497Z 0.6 https://www.clinicalobserver.com/public-health/spain-reports-possible-person-to-person-swine-flu-case 2026-10-30T17:59:45.602Z 0.6 https://www.clinicalobserver.com/research/merck-drug-cuts-death-risk-by-a-third-in-advanced-endometrial-cancer 2026-11-02T14:08:59.537Z 0.6 https://www.clinicalobserver.com/hospitals/unm-health-diverts-ambulances-and-closes-clinics-after-cybersecurity-event 2026-10-30T18:29:41.876Z 0.6 https://www.clinicalobserver.com/policy/chinese-regulator-approves-bayer-blood-thinner-asundexian 2026-10-30T18:29:50.592Z 0.6 https://www.clinicalobserver.com/public-health/swiss-ebola-patient-arrives-in-geneva-after-evacuation-from-nigeria 2026-10-30T19:29:59.126Z 0.6 https://www.clinicalobserver.com/research/sacituzumab-tirumotecan-plus-pembrolizumab-improves-pfs-in-pd-l1-negative-nsclc 2026-10-30T20:14:58.182Z 0.6 https://www.clinicalobserver.com/public-health/nigeria-reports-first-bundibugyo-ebola-case-as-global-outbreak-tops-9-700 2026-10-30T20:15:15.097Z 0.6 https://www.clinicalobserver.com/biotech/tarlatamab-plus-durvalumab-cut-death-risk-58-in-first-line-small-cell-lung 2026-10-25T17:54:12.649Z 0.6 https://www.clinicalobserver.com/public-health/uganda-imposes-21-day-quarantine-on-citizens-returning-from-drc 2026-10-30T20:45:14.802Z 0.6 https://www.clinicalobserver.com/public-health/three-die-in-suspected-hantavirus-outbreak-on-atlantic-cruise-ship 2026-10-30T21:00:18.883Z 0.6 https://www.clinicalobserver.com/research/first-ebola-vaccine-trial-in-dr-congo-begins-in-bunia 2026-10-30T22:00:28.007Z 0.6 https://www.clinicalobserver.com/public-health/kenya-searches-for-missing-ugandan-ebola-contact-as-cases-rise-to-nine 2026-10-30T22:15:47.293Z 0.6 https://www.clinicalobserver.com/public-health/swiss-national-is-first-ebola-bundibugyo-case-in-nigeria 2026-10-30T22:29:42.449Z 0.6 https://www.clinicalobserver.com/public-health/kenya-reports-second-ebola-death-with-no-community-spread 2026-10-26T04:54:40.694Z 0.6 https://www.clinicalobserver.com/biotech/merck-and-moderna-report-phase-3-cancer-vaccine-data-early-after-leak 2026-10-30T22:30:06.062Z 0.6 https://www.clinicalobserver.com/public-health/nigeria-confirms-first-ebola-case-in-more-than-a-decade 2026-10-23T23:19:46.060Z 0.6 https://www.clinicalobserver.com/research/mrna-melanoma-vaccine-plus-keytruda-cut-recurrence-risk-by-42-in-phase-3 2026-10-30T22:45:39.114Z 0.6 https://www.clinicalobserver.com/biotech/brepocitinib-meets-primary-endpoint-in-two-phase-3-uveitis-trials 2026-10-30T23:00:06.654Z 0.6 https://www.clinicalobserver.com/biotech/izalontamab-brengitecan-cuts-progression-risk-by-59-in-hr-her2-breast-cancer 2026-10-30T23:00:39.915Z 0.6 https://www.clinicalobserver.com/hospitals/mass-general-brigham-cuts-staff-and-halves-home-hospital 2026-10-23T20:32:27.411Z 0.6 https://www.clinicalobserver.com/public-health/us-measles-cases-reach-4-588-as-pennsylvania-reports-1-338 2026-10-30T23:14:53.569Z 0.6 https://www.clinicalobserver.com/biotech/bristol-myers-squibb-reports-death-in-autoimmune-car-t-trial 2026-10-30T23:15:09.451Z 0.6 https://www.clinicalobserver.com/policy/fda-approves-bepirovirsen-for-chronic-hepatitis-b 2026-10-30T23:44:26.201Z 0.6 https://www.clinicalobserver.com/public-health/kansas-elementary-school-norovirus-outbreak-ends-with-97-sick 2026-10-30T23:44:40.089Z 0.6 https://www.clinicalobserver.com/policy/fda-finalizes-software-labeling-guidance-for-drug-sponsors 2026-10-31T01:14:44.642Z 0.6 https://www.clinicalobserver.com/biotech/telehealth-platforms-prescribe-glp-1s-off-label-for-addiction 2026-10-31T01:29:24.986Z 0.6 https://www.clinicalobserver.com/research/pembrolizumab-plus-chemotherapy-improves-pcr-in-triple-negative-breast-cancer 2026-10-31T01:44:22.730Z 0.6 https://www.clinicalobserver.com/biotech/otsuka-reports-phase-3-data-showing-voyxact-cut-kidney-decline-risk-in-iga 2026-10-31T01:59:34.413Z 0.6 https://www.clinicalobserver.com/biotech/fda-accepts-biohaven-s-troriluzole-resubmission 2026-10-31T02:14:46.951Z 0.6 https://www.clinicalobserver.com/research/gilead-posts-phase-3-results-for-bictegravir-lenacapavir 2026-10-31T02:29:39.504Z 0.6 https://www.clinicalobserver.com/biotech/fda-approves-first-of-its-kind-chronic-hepatitis-b-treatment 2026-10-25T02:23:39.048Z 0.6 https://www.clinicalobserver.com/public-health/nigeria-confirms-travel-linked-ebola-case-as-africa-cdc-calls-crisis-meeting 2026-10-31T02:59:41.617Z 0.6 https://www.clinicalobserver.com/research/esmo-2026-cancer-data-split-practice-changing-wins-from-early-signals 2026-10-31T03:14:29.461Z 0.6 https://www.clinicalobserver.com/biotech/openai-acquires-orchestra-bio-deepening-ai-s-drug-development-push 2026-10-25T18:54:35.511Z 0.6 https://www.clinicalobserver.com/public-health/nigeria-confirms-first-ebola-case-as-regional-outbreak-spreads 2026-10-24T12:31:23.496Z 0.6 https://www.clinicalobserver.com/hospitals/nonprofit-hospital-mergers-expand-across-the-midwest 2026-10-31T03:29:39.519Z 0.6 https://www.clinicalobserver.com/policy/fda-adds-advisers-as-review-finds-pharma-ties 2026-10-31T03:44:29.312Z 0.6 https://www.clinicalobserver.com/research/retatrutide-and-amylin-combos-move-toward-regulatory-decisions 2026-10-31T03:59:26.536Z 0.6 https://www.clinicalobserver.com/hospitals/mass-general-brigham-nurses-withdraw-strike-notice 2026-10-31T03:59:47.946Z 0.6 https://www.clinicalobserver.com/research/trial-design-and-comparator-choices-shape-the-wave-of-phase-3-failures 2026-10-31T04:14:37.925Z 0.6 https://www.clinicalobserver.com/biotech/bristol-myers-zenbexus-win-leaves-shares-lower 2026-10-31T04:14:35.996Z 0.6 https://www.clinicalobserver.com/research/mixed-phase-2-and-3-results-test-rare-disease-and-neurology-therapies 2026-10-31T05:29:33.179Z 0.6 https://www.clinicalobserver.com/public-health/us-measles-count-reaches-3-659-as-outbreaks-spread 2026-10-31T05:45:21.158Z 0.6 https://www.clinicalobserver.com/policy/fda-advisory-panel-recommends-grails-galleri-blood-test 2026-10-22T22:56:03.837Z 0.6 https://www.clinicalobserver.com/biotech/biotech-funding-rebounds-but-young-startups-lag-behind 2026-10-31T06:14:26.165Z 0.6 https://www.clinicalobserver.com/biotech/b7-h3-adcs-extend-survival-in-relapsed-small-cell-lung-cancer 2026-10-31T06:59:28.956Z 0.6 https://www.clinicalobserver.com/biotech/ziltivekimab-fails-while-tezspire-and-efgartigimod-succeed-in-immunology 2026-10-30T17:56:33.570Z 0.6 https://www.clinicalobserver.com/public-health/study-finds-at-least-25-of-former-nfl-players-who-died-2016-to-2021-had-cte 2026-10-30T14:26:38.141Z 0.6 https://www.clinicalobserver.com/about monthly 0.2 https://www.clinicalobserver.com/standards monthly 0.2 https://www.clinicalobserver.com/corrections monthly 0.2 https://www.clinicalobserver.com/ownership monthly 0.2 https://www.clinicalobserver.com/contact monthly 0.2 https://www.clinicalobserver.com/advertise monthly 0.2 https://www.clinicalobserver.com/newsletter monthly 0.2 https://www.clinicalobserver.com/careers monthly 0.2 https://www.clinicalobserver.com/privacy monthly 0.2 https://www.clinicalobserver.com/terms monthly 0.2 https://www.clinicalobserver.com/cookies monthly 0.2 https://www.clinicalobserver.com/accessibility monthly 0.2